Cargando…

5hmC Level Predicts Biochemical Failure Following Radical Prostatectomy in Prostate Cancer Patients with ERG Negative Tumors

This study aimed to validate whether 5-hydroxymethylcytosine (5hmC) level in combination with ERG expression is a predictive biomarker for biochemical failure (BF) in men undergoing radical prostatectomy (RP) for prostate cancer (PCa). The study included 592 PCa patients from two consecutive Danish...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kristensen, Gitte, Strand, Siri H., Røder, Martin Andreas, Berg, Kasper Drimer, Toft, Birgitte Grønkær, Høyer, Søren, Borre, Michael, Sørensen, Karina Dalsgaard, Brasso, Klaus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429366/ https://www.ncbi.nlm.nih.gov/pubmed/30818754 http://dx.doi.org/10.3390/ijms20051025

Ejemplares similares

High levels of 5-hydroxymethylcytosine (5hmC) is an adverse predictor of biochemical recurrence after prostatectomy in ERG-negative prostate cancer
por: Strand, Siri H., et al.
Publicado: (2015)

AZGP1 Protein Expression in Hormone-Naïve Advanced Prostate Cancer Treated with Primary Androgen Deprivation Therapy
por: Winther, Mads Dochedahl, et al.
Publicado: (2020)

Dysregulation and prognostic potential of 5-methylcytosine (5mC), 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) levels in prostate cancer
por: Storebjerg, Tine Maj, et al.
Publicado: (2018)

The Association between Plasma Levels of Intact and Cleaved uPAR Levels and the Risk of Biochemical Recurrence after Radical Prostatectomy for Prostate Cancer
por: Stroomberg, Hein Vincent, et al.
Publicado: (2020)

Validation of the four-miRNA biomarker panel MiCaP for prediction of long-term prostate cancer outcome
por: Strand, Siri H., et al.
Publicado: (2020)

Global DNA 5hmC and CK19(5hmC+) Contents: A Promising Biomarker for Predicting Prognosis in Small Hepatocellular Carcinoma
por: Jiang, Jinhua, et al.
Publicado: (2021)

High miR-449b expression in prostate cancer is associated with biochemical recurrence after radical prostatectomy
por: Mortensen, Martin Mørck, et al.
Publicado: (2014)

Exploring role of 5hmC as potential marker of chemoresistance
por: Kharat, Suhas S., et al.
Publicado: (2020)

Expression profiling of prostate cancer tissue delineates genes associated with recurrence after prostatectomy
por: Mortensen, Martin Mørck, et al.
Publicado: (2015)

TET Enzymes and 5hmC in Adaptive and Innate Immune Systems
por: Lio, Chan-Wang J., et al.
Publicado: (2019)

Elevated 5hmC levels characterize DNA of the cerebellum in Parkinson’s disease
por: Stöger, Reinhard, et al.
Publicado: (2017)

New Insights into 5hmC DNA Modification: Generation, Distribution and Function
por: Shi, Dong-Qiao, et al.
Publicado: (2017)

5hmC modification regulates R-loop accumulation in response to stress
por: Xu, Xingyun, et al.
Publicado: (2023)

Exploring the transcriptome of hormone-naive multifocal prostate cancer and matched lymph node metastases
por: Schmidt, Linnéa, et al.
Publicado: (2018)

Crystal structure of the 5hmC specific endonuclease PvuRts1I
por: Kazrani, Asgar Abbas, et al.
Publicado: (2014)

De novo DNA methylation drives 5hmC accumulation in mouse zygotes
por: Amouroux, Rachel, et al.
Publicado: (2016)

Alterations in the Genomic Distribution of 5hmC in In Vivo Aged Human Skin Fibroblasts
por: Kołodziej-Wojnar, Paulina, et al.
Publicado: (2020)

Heterogeneous patterns of DNA methylation-based field effects in histologically normal prostate tissue from cancer patients
por: Møller, Mia, et al.
Publicado: (2017)

5-hmC in the brain is abundant in synaptic genes and shows differences at the exon-intron boundary
por: Khare, Tarang, et al.
Publicado: (2012)

Analysis of archaic human haplotypes suggests that 5hmC acts as an epigenetic guide for NCO recombination
por: Lee, Bernett, et al.
Publicado: (2022)

Standardized Computer-Assisted Analysis of 5-hmC Immunoreactivity in Dysplastic Nevi and Superficial Spreading Melanomas
por: Koch, Elias A. T., et al.
Publicado: (2023)

Alterations of the expression of TET2 and DNA 5-hmC predict poor prognosis in Myelodysplastic Neoplasms
por: Seethy, Ashikh A., et al.
Publicado: (2023)

5hmC Immunohistochemistry: A Predictor of TERT Promoter Mutational Status in Follicular Thyroid Carcinoma?
por: Hysek, Martin, et al.
Publicado: (2023)

RHCG and TCAF1 promoter hypermethylation predicts biochemical recurrence in prostate cancer patients treated by radical prostatectomy
por: Strand, Siri H., et al.
Publicado: (2016)

Combined methylation mapping of 5mC and 5hmC during early embryonic stages in bovine
por: de Montera, Béatrice, et al.
Publicado: (2013)

A Comparative Study on 5hmC Targeting Regulation of Neurons in AD Mice by Several Natural Compounds
por: Cao, Dongyi, et al.
Publicado: (2020)

Supplemental Herbal Choline Increases 5-hmC DNA on Whole Blood from Pregnant Ewes and Offspring
por: Roque-Jiménez, José Alejandro, et al.
Publicado: (2020)

Epigenomic analysis of 5-hydroxymethylcytosine (5hmC) reveals novel DNA methylation markers for lung cancers
por: Wang, Zhihui, et al.
Publicado: (2020)

TET2 Promotes Keloid Hyperplasia by Regulating 5hmC Modification in the TGFβ Promoter Region
por: Niu, Changying, et al.
Publicado: (2023)

Cellular Composition and 5hmC Signature Predict the Treatment Response of AML Patients to Azacitidine Combined with Chemotherapy
por: Liang, Guanghao, et al.
Publicado: (2023)

First Danish Single-Institution Experience with Radical Prostatectomy: Biochemical Outcome in 1200 Consecutive Patients
por: Røder, M. Andreas, et al.
Publicado: (2011)

Novel diagnostic and prognostic classifiers for prostate cancer identified by genome-wide microRNA profiling
por: Kristensen, Helle, et al.
Publicado: (2016)

Biomarker potential of ST6GALNAC3 and ZNF660 promoter hypermethylation in prostate cancer tissue and liquid biopsies
por: Haldrup, Christa, et al.
Publicado: (2018)

5mC and 5hmC dynamics during PGC reprogramming and role of Tet1 in female meiosis
por: Yamaguchi, Shinpei, et al.
Publicado: (2013)

IDH1/2 Mutants Inhibit TET-Promoted Oxidation of RNA 5mC to 5hmC
por: Xu, Qiang, et al.
Publicado: (2016)

Tet2 Regulates Osteoclast Differentiation by Interacting with Runx1 and Maintaining Genomic 5-Hydroxymethylcytosine (5hmC)
por: Chu, Yajing, et al.
Publicado: (2018)

iRNA5hmC: The First Predictor to Identify RNA 5-Hydroxymethylcytosine Modifications Using Machine Learning
por: Liu, Yuan, et al.
Publicado: (2020)

Values of 5mC, 5hmC, and TET2 for identifying the presence and progression of breast precancerous lesion
por: Zhang, Zijing, et al.
Publicado: (2019)

β2SP/TET2 complex regulates gene 5hmC modification after cerebral ischemia
por: Ma, Xiaohua, et al.
Publicado: (2021)

5-Hydroxymethylcytosine (5hmC) at or near cancer mutation hot spots as potential targets for early cancer detection
por: Lu, Michael J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_to4000hc7j84pnit8i8nvvsprd